What is minimal residual disease (MRD) testing
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Minimal Residual Disease (MRD) Testing
Minimal residual disease (MRD) testing is a highly sensitive blood test that detects tiny amounts of cancer cells remaining in your body after treatment—often at levels too small to show up on imaging scans like CT or PET scans.
How It Works
Think of it this way: Standard imaging can detect tumors when they contain millions of cancer cells. MRD testing can detect as few as 1 cancer cell among 1 million normal cells. The test looks for:
- Cancer DNA fragments in the bloodstream (called "circulating tumor DNA" or ctDNA)
- Abnormal blood cells (in blood cancers like leukemia and lymphoma)
- Genetic mutations specific to your cancer
Why Doctors Use MRD Testing
According to NCCN Guidelines and ASCO recommendations, MRD testing helps doctors:
- Assess treatment response - Determine if your current treatment is working effectively
- Predict outcomes - Undetectable MRD often correlates with better long-term survival
- Guide treatment decisions - Results may influence whether to continue, change, or stop treatment
- Monitor for recurrence - Detect cancer returning earlier than traditional imaging
What Results Mean
- MRD-negative (undetectable): No cancer cells detected at the sensitivity level tested—generally a positive sign
- MRD-positive (detectable): Cancer cells are present, which may prompt treatment adjustments
Important Context
MRD testing is increasingly used in several cancers including:
- Acute leukemias (ALL, AML)
- Chronic lymphocytic leukemia (CLL)
- Multiple myeloma
- Some solid tumors (breast cancer, colorectal cancer)
However, not all cancers routinely use MRD testing yet, and its clinical significance varies by cancer type.
Questions to Ask Your Doctor
If your care team mentions MRD testing:
- Is MRD testing recommended for my specific cancer type?
- What will the results tell us about my treatment response?
- How will MRD results affect my treatment plan?
- How often will I be tested, and when will we get results?
- What does it mean if my MRD is positive vs. negative?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ